GPC2 and neuroblastoma: While GPC2 CARs lose cytotoxicity in the context of GPC2 ablation and CD276 lose cytotoxicity in the context of CD276 ablation, BiCisCARs retained cytotoxicity with both GPC2KO and CD276KO neuroblastoma cells.